Please enable JavaScript to continue using this application.

Compare $IBIO vs $INMB | Chartloom

Compare

$IBIO vs $INMB

iBio Inc · INmune Bio Inc

IBIO

iBio Inc

INMB

INmune Bio Inc

Compare $IBIO vs $INMB

Comparing iBio Inc and INmune Bio Inc

IBIOiBio Inc

INMBINmune Bio Inc

IBIOiBio Inc

Market cap

$43M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-75.0%

YTD performance

-56.9%

52W performance

0.5%

FCF yield

-55.0%

INMBINmune Bio Inc

Market cap

$50M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

22.7%

52W performance

-6.0%

FCF yield

-31.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IBIO

INMB

Detailed metrics comparison

IBIO

iBio Inc

INMB

INmune Bio Inc

Market Cap

IBIO$43M

INMB$50M

Enterprise Value

IBIO$-13M

INMB$32M

Price

IBIO$0.87

INMB$1.89

P/E Ratio

IBION/A

INMBN/A

P/S Ratio

IBIO432.71x

INMB1,071.30x

EV/Sales

IBIO-131.24x

INMB703.08x

EV/EBITDA

IBIO0.00x

INMB0.00x

P/B Ratio

IBIO0.80x

INMB2.63x

P/FCF Ratio

IBION/A

INMBN/A

EV/FCF

IBIO0.55x

INMB-2.02x

PEG Ratio

IBION/A

INMBN/A

Forward P/E (NTM)

IBION/A

INMBN/A

Forward P/S (NTM)

IBION/A

INMBN/A

Revenue (TTM)

IBIO$100K

INMB$0

Revenue Growth (YoY)

IBIO-75.0%

INMB-100.0%

Forward Rev Growth

IBIO33.3%

INMB150.6%

Gross Margin (TTM)

IBIO52.1%

INMB0.0%

Operating Margin (TTM)

IBIO0.0%

INMB0.0%

EBITDA Margin (TTM)

IBIO-24492.0%

INMB0.0%

Net Margin (TTM)

IBIO-33044.0%

INMB0.0%

FCF Margin (TTM)

IBIO-23796.0%

INMBN/A

Net Income (TTM)

IBIO$-33M

INMB$-18M

FCF (TTM)

IBIO$-24M

INMB$-16M

EPS (TTM)

IBIO-$0.23

INMB-$0.69

ROE (TTM)

IBIO-4792.0%

INMB-8287.0%

ROA (TTM)

IBIO-4216.0%

INMB-6223.0%

ROIC (TTM)

IBIO-4779.0%

INMB-8287.0%

Cash

IBIO$56M

INMB$18M

Debt

IBIO$0

INMB$0

Net Cash/Debt

IBIO$56M

INMB$18M

Current Ratio (TTM)

IBIO7.85x

INMB4.04x

Quick Ratio (TTM)

IBIO7.59x

INMB3.94x

Debt/Equity (TTM)

IBIO0.91x

INMB0.00x

Debt/Assets (TTM)

IBIO0.0%

INMB0.0%

Interest Coverage (TTM)

IBION/A

INMBN/A

Net Debt/EBITDA (TTM)

IBIO0.00x

INMB0.00x

Beta

IBIO1.42

INMB0.91

52W Performance

IBIO0.5%

INMB-6.0%

YTD Performance

IBIO-56.9%

INMB22.7%

% from 52W High

IBIO-77.2%

INMB-27.3%

% from 52W Low

IBIO11.5%

INMB73.4%

Asset Turnover (TTM)

IBIO0.01x

INMB0.00x

FCF Yield (TTM)

IBIO-55.0%

INMB-31.3%

Earnings Yield (TTM)

IBIO-76.4%

INMB-36.6%

Dividend Yield (TTM)

IBION/A

INMBN/A

Rule of 40

IBIO-23,871.0

INMB-100.0

EV/GP/RG

IBION/A

INMBN/A

Ticker research

View IBIO research View INMB research

Metric	IBIO iBio Inc	INMB INmune Bio Inc
Market & Valuation
Market Cap	$43M	$50M
Enterprise Value	$-13M	$32M
Price	$0.87	$1.89
P/E Ratio	N/A	N/A
P/S Ratio	432.71x	1,071.30x
EV/Sales	-131.24x	703.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.80x	2.63x
P/FCF Ratio	N/A	N/A
EV/FCF	0.55x	-2.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$100K	$0
Revenue Growth (YoY)	-75.0%	-100.0%
Forward Rev Growth	33.3%	150.6%
Profitability
Gross Margin (TTM)	52.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-24492.0%	0.0%
Net Margin (TTM)	-33044.0%	0.0%
FCF Margin (TTM)	-23796.0%	N/A
Net Income (TTM)	$-33M	$-18M
FCF (TTM)	$-24M	$-16M
EPS (TTM)	-$0.23	-$0.69
ROE (TTM)	-4792.0%	-8287.0%
ROA (TTM)	-4216.0%	-6223.0%
ROIC (TTM)	-4779.0%	-8287.0%
Financial Health
Cash	$56M	$18M
Debt	$0	$0
Net Cash/Debt	$56M	$18M
Current Ratio (TTM)	7.85x	4.04x
Quick Ratio (TTM)	7.59x	3.94x
Debt/Equity (TTM)	0.91x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.42	0.91
52W Performance	0.5%	-6.0%
YTD Performance	-56.9%	22.7%
% from 52W High	-77.2%	-27.3%
% from 52W Low	11.5%	73.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-55.0%	-31.3%
Earnings Yield (TTM)	-76.4%	-36.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-23,871.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View IBIO research	View INMB research

Valuation

P/S Ratio

IBIO

432.71x

INMB

1,071.30x

EV/FCF

INMB

-2.02x

IBIO

0.55x

Growth & revenue

Revenue Growth TTM

IBIO

-75.0%

INMB

-100.0%

Forward Revenue Growth

INMB

150.6%

IBIO

33.3%

Profitability & performance

Gross Margin

IBIO

52.1%

INMB

0.0%

ROE

IBIO

-4792.0%

INMB

-8287.0%

FCF Yield %

INMB

-31.3%

IBIO

-55.0%

52-Week Performance

IBIO

0.5%

INMB

-6.0%

Detailed metrics comparison

IBIO

iBio Inc

INMB

INmune Bio Inc

Market Cap

IBIO$43M

INMB$50M

Enterprise Value

IBIO$-13M

INMB$32M

Price

IBIO$0.87

INMB$1.89

P/E Ratio

IBION/A

INMBN/A

P/S Ratio

IBIO432.71x

INMB1,071.30x

EV/Sales

IBIO-131.24x

INMB703.08x

EV/EBITDA

IBIO0.00x

INMB0.00x

P/B Ratio

IBIO0.80x

INMB2.63x

P/FCF Ratio

IBION/A

INMBN/A

EV/FCF

IBIO0.55x

INMB-2.02x

PEG Ratio

IBION/A

INMBN/A

Forward P/E (NTM)

IBION/A

INMBN/A

Forward P/S (NTM)

IBION/A

INMBN/A

Revenue (TTM)

IBIO$100K

INMB$0

Revenue Growth (YoY)

IBIO-75.0%

INMB-100.0%

Forward Rev Growth

IBIO33.3%

INMB150.6%

Gross Margin (TTM)

IBIO52.1%

INMB0.0%

Operating Margin (TTM)

IBIO0.0%

INMB0.0%

EBITDA Margin (TTM)

IBIO-24492.0%

INMB0.0%

Net Margin (TTM)

IBIO-33044.0%

INMB0.0%

FCF Margin (TTM)

IBIO-23796.0%

INMBN/A

Net Income (TTM)

IBIO$-33M

INMB$-18M

FCF (TTM)

IBIO$-24M

INMB$-16M

EPS (TTM)

IBIO-$0.23

INMB-$0.69

ROE (TTM)

IBIO-4792.0%

INMB-8287.0%

ROA (TTM)

IBIO-4216.0%

INMB-6223.0%

ROIC (TTM)

IBIO-4779.0%

INMB-8287.0%

Cash

IBIO$56M

INMB$18M

Debt

IBIO$0

INMB$0

Net Cash/Debt

IBIO$56M

INMB$18M

Current Ratio (TTM)

IBIO7.85x

INMB4.04x

Quick Ratio (TTM)

IBIO7.59x

INMB3.94x

Debt/Equity (TTM)

IBIO0.91x

INMB0.00x

Debt/Assets (TTM)

IBIO0.0%

INMB0.0%

Interest Coverage (TTM)

IBION/A

INMBN/A

Net Debt/EBITDA (TTM)

IBIO0.00x

INMB0.00x

Beta

IBIO1.42

INMB0.91

52W Performance

IBIO0.5%

INMB-6.0%

YTD Performance

IBIO-56.9%

INMB22.7%

% from 52W High

IBIO-77.2%

INMB-27.3%

% from 52W Low

IBIO11.5%

INMB73.4%

Asset Turnover (TTM)

IBIO0.01x

INMB0.00x

FCF Yield (TTM)

IBIO-55.0%

INMB-31.3%

Earnings Yield (TTM)

IBIO-76.4%

INMB-36.6%

Dividend Yield (TTM)

IBION/A

INMBN/A

Rule of 40

IBIO-23,871.0

INMB-100.0

EV/GP/RG

IBION/A

INMBN/A

Ticker research

View IBIO research View INMB research

Metric	IBIO iBio Inc	INMB INmune Bio Inc
Market & Valuation
Market Cap	$43M	$50M
Enterprise Value	$-13M	$32M
Price	$0.87	$1.89
P/E Ratio	N/A	N/A
P/S Ratio	432.71x	1,071.30x
EV/Sales	-131.24x	703.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.80x	2.63x
P/FCF Ratio	N/A	N/A
EV/FCF	0.55x	-2.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$100K	$0
Revenue Growth (YoY)	-75.0%	-100.0%
Forward Rev Growth	33.3%	150.6%
Profitability
Gross Margin (TTM)	52.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-24492.0%	0.0%
Net Margin (TTM)	-33044.0%	0.0%
FCF Margin (TTM)	-23796.0%	N/A
Net Income (TTM)	$-33M	$-18M
FCF (TTM)	$-24M	$-16M
EPS (TTM)	-$0.23	-$0.69
ROE (TTM)	-4792.0%	-8287.0%
ROA (TTM)	-4216.0%	-6223.0%
ROIC (TTM)	-4779.0%	-8287.0%
Financial Health
Cash	$56M	$18M
Debt	$0	$0
Net Cash/Debt	$56M	$18M
Current Ratio (TTM)	7.85x	4.04x
Quick Ratio (TTM)	7.59x	3.94x
Debt/Equity (TTM)	0.91x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.42	0.91
52W Performance	0.5%	-6.0%
YTD Performance	-56.9%	22.7%
% from 52W High	-77.2%	-27.3%
% from 52W Low	11.5%	73.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-55.0%	-31.3%
Earnings Yield (TTM)	-76.4%	-36.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-23,871.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View IBIO research	View INMB research